BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 9618075)

  • 1. HIV type 1-reactive chemokine-producing CD8+ and CD4+ cells expanded from infected lymph nodes.
    Triozzi PL; Bresler HS; Aldrich WA
    AIDS Res Hum Retroviruses; 1998 May; 14(8):643-9. PubMed ID: 9618075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro.
    Oliva A; Kinter AL; Vaccarezza M; Rubbert A; Catanzaro A; Moir S; Monaco J; Ehler L; Mizell S; Jackson R; Li Y; Romano JW; Fauci AS
    J Clin Invest; 1998 Jul; 102(1):223-31. PubMed ID: 9649576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-gamma and IL-12 differentially regulate CC-chemokine secretion and CCR5 expression in human T lymphocytes.
    Losana G; Bovolenta C; Rigamonti L; Borghi I; Altare F; Jouanguy E; Forni G; Casanova JL; Sherry B; Mengozzi M; Trinchieri G; Poli G; Gerosa F; Novelli F
    J Leukoc Biol; 2002 Oct; 72(4):735-42. PubMed ID: 12377943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive association between beta-chemokine-producing T cells and HIV type 1 viral load in HIV-infected subjects in Abidjan, Côte d'Ivoire.
    Jennes W; Sawadogo S; Koblavi-Dème S; Vuylsteke B; Maurice C; Roels TH; Chorba T; Nkengasong JN; Kestens L
    AIDS Res Hum Retroviruses; 2002 Feb; 18(3):171-7. PubMed ID: 11839151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifactorial nature of noncytolytic CD8+ T cell-mediated suppression of HIV replication: beta-chemokine-dependent and -independent effects.
    Rubbert A; Weissman D; Combadiere C; Pettrone KA; Daucher JA; Murphy PM; Fauci AS
    AIDS Res Hum Retroviruses; 1997 Jan; 13(1):63-9. PubMed ID: 8989428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous production of beta-chemokines by CD4+, but not CD8+, T-cell clones correlates with the clinical state of human immunodeficiency virus type 1 (HIV-1)-infected individuals and may be responsible for blocking infection with non-syncytium-inducing HIV-1 in vitro.
    Saha K; Bentsman G; Chess L; Volsky DJ
    J Virol; 1998 Jan; 72(1):876-81. PubMed ID: 9420304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies.
    Chun TW; Justement JS; Moir S; Hallahan CW; Ehler LA; Liu S; McLaughlin M; Dybul M; Mican JM; Fauci AS
    Proc Natl Acad Sci U S A; 2001 Jan; 98(1):253-8. PubMed ID: 11136258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-CD4 cytotoxic T lymphocyte (CTL) activity in HIV+ patients: flow cytometric analysis.
    Yamamura Y; Rodriguez N; Schwartz A; Eylar E; Yano N
    Cell Mol Biol (Noisy-le-grand); 1995; 41 Suppl 1():S133-44. PubMed ID: 8574141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV replication in CD4+ T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous beta-chemokines and the viral inductive effects of other endogenous cytokines.
    Kinter AL; Ostrowski M; Goletti D; Oliva A; Weissman D; Gantt K; Hardy E; Jackson R; Ehler L; Fauci AS
    Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14076-81. PubMed ID: 8943063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated peripheral CD8 lymphocytes express CD4 in vivo and are targets for infection by human immunodeficiency virus type 1.
    Imlach S; McBreen S; Shirafuji T; Leen C; Bell JE; Simmonds P
    J Virol; 2001 Dec; 75(23):11555-64. PubMed ID: 11689637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular immunotherapy of advanced human immunodeficiency virus type 1 infection using autologous lymph node lymphocytes: effects on chemokine production.
    Triozzi PL; Aldrich W; Bresler HS; Para MF; Flancbaum LJ
    J Infect Dis; 1999 Jan; 179(1):245-8. PubMed ID: 9841848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.
    Letessier EM; Heo DS; Okarma T; Johnson JT; Herberman RB; Whiteside TL
    Cancer Res; 1991 Aug; 51(15):3891-9. PubMed ID: 1677310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infection of the CD45RA+ (naive) subset of peripheral CD8+ lymphocytes by human immunodeficiency virus type 1 in vivo.
    McBreen S; Imlach S; Shirafuji T; Scott GR; Leen C; Bell JE; Simmonds P
    J Virol; 2001 May; 75(9):4091-102. PubMed ID: 11287558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+ T cell depletion.
    van Praag RM; Prins JM; Roos MT; Schellekens PT; Ten Berge IJ; Yong SL; Schuitemaker H; Eerenberg AJ; Jurriaans S; de Wolf F; Fox CH; Goudsmit J; Miedema F; Lange JM
    J Clin Immunol; 2001 May; 21(3):218-26. PubMed ID: 11403229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of CD8 lymphocyte activation with cellular viremia and plasma HIV RNA levels in asymptomatic patients infected by human immunodeficiency virus type 1.
    Bouscarat F; Levacher-Clergeot M; Dazza MC; Strauss KW; Girard PM; Ruggeri C; Sinet M
    AIDS Res Hum Retroviruses; 1996 Jan; 12(1):17-24. PubMed ID: 8825614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High levels of CD8-positive lymphocytes expressing CD45R0, granzyme B, and Ki-67 in lymph nodes of HIV-infected individuals are not associated with increased mortality.
    Espersen C; Pakkenberg B; Harder E; Pallesen G; Gerstoft J; Pedersen BK; Ullum H
    AIDS Res Hum Retroviruses; 2001 Mar; 17(4):287-93. PubMed ID: 11242516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous activation of viral antigen-specific memory CD4+ and CD8+ T-cells using mRNA-electroporated CD40-activated autologous B-cells.
    Van den Bosch GA; Van Gulck E; Ponsaerts P; Nijs G; Lenjou M; Apers L; Kint I; Heyndrickx L; Vanham G; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF
    J Immunother; 2006; 29(5):512-23. PubMed ID: 16971807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HTLV-II down-regulates HIV-1 replication in IL-2-stimulated primary PBMC of coinfected individuals through expression of MIP-1alpha.
    Casoli C; Vicenzi E; Cimarelli A; Magnani G; Ciancianaini P; Cattaneo E; Dall'Aglio P; Poli G; Bertazzoni U
    Blood; 2000 May; 95(9):2760-9. PubMed ID: 10779418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD8+ T cells from HIV type 1-seronegative individuals suppress virus replication in acutely infected cells.
    Røsok B; Voltersvik P; Larsson BM; Albert J; Brinchmann JE; Asjö B
    AIDS Res Hum Retroviruses; 1997 Jan; 13(1):79-85. PubMed ID: 8989430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell-derived suppressive activity: evidence of autocrine noncytolytic control of HIV type 1 transcription and replication.
    Leith JG; Copeland KF; McKay PJ; Bienzle D; Richards CD; Rosenthal KL
    AIDS Res Hum Retroviruses; 1999 Nov; 15(17):1553-61. PubMed ID: 10580406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.